Livzon Pharmaceutical Group Inc
SZSE:000513

Watchlist Manager
Livzon Pharmaceutical Group Inc Logo
Livzon Pharmaceutical Group Inc
SZSE:000513
Watchlist
Price: 36.82 CNY -3.18% Market Closed
Market Cap: 34B CNY
Have any thoughts about
Livzon Pharmaceutical Group Inc?
Write Note

Livzon Pharmaceutical Group Inc
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Livzon Pharmaceutical Group Inc
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Livzon Pharmaceutical Group Inc
SZSE:000513
Net Change in Cash
ÂĄ995.4m
CAGR 3-Years
-9%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Net Change in Cash
ÂĄ3.3B
CAGR 3-Years
N/A
CAGR 5-Years
37%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Net Change in Cash
ÂĄ6.1B
CAGR 3-Years
131%
CAGR 5-Years
26%
CAGR 10-Years
45%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Net Change in Cash
ÂĄ4.4B
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
13%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Net Change in Cash
ÂĄ1.6B
CAGR 3-Years
-25%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Net Change in Cash
-ÂĄ609m
CAGR 3-Years
-45%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Livzon Pharmaceutical Group Inc
Glance View

Market Cap
34B CNY
Industry
Pharmaceuticals

Livzon Pharmaceutical Group Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Zhuhai, Guangdong and currently employs 8,580 full-time employees. LIVZON PHARMACEUTICAL GROUP INC. is a China based company principally engaged in the research and development, production and sales of pharmaceutical products. The firm's main products include western medicine preparation such as gastrointestinal drugs, cardiovascular drugs and antimicrobial drugs and gonadotrophin drugs, Chinese medicine preparation, active pharmaceutical ingredient and intermediates, diagnostic reagents and equipments. The firm distributes its products in the domestic market and to overseas markets.

Intrinsic Value
48.61 CNY
Undervaluation 24%
Intrinsic Value
Price

See Also

What is Livzon Pharmaceutical Group Inc's Net Change in Cash?
Net Change in Cash
995.4m CNY

Based on the financial report for Jun 30, 2024, Livzon Pharmaceutical Group Inc's Net Change in Cash amounts to 995.4m CNY.

What is Livzon Pharmaceutical Group Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
-6%

Over the last year, the Net Change in Cash growth was -23%. The average annual Net Change in Cash growth rates for Livzon Pharmaceutical Group Inc have been -9% over the past three years , -6% over the past five years .

Back to Top